Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Peptide containing doai
Patent
1992-07-31
1994-06-21
Schain, Howard E.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Peptide containing doai
514 12, 514 21, 530380, 530397, A61K 3724, C07K 1514
Patent
active
053228375
ABSTRACT:
A method for purifying erythropoietin is described. The method comprises treating partially purifying erythropoietin by reverse phase high performance liquid chromatography to obtain homogeneous erythropoietin having a molecular weight of about 34,000 daltons on SDS PAGE and moving a single peak on reverse phase HPLC. The homogeneous erythropoietin protein preferably has a specific activity of at least 120,000 IU, more preferably at least 160,000 IU per absorbance unit at 280 nm.
REFERENCES:
patent: 4289690 (1981-09-01), Pestka et al.
patent: 4558005 (1985-12-01), Goldwasser et al.
patent: 4568488 (1986-02-01), Lee-Huang
patent: 4677195 (1987-01-01), Hewick et al.
patent: 4703008 (1987-10-01), Lin
Miyake et al., J. Biol. Chem., 252, 5558-5564 (1977).
Hewick Rodney M.
Seenra Jasbir S.
Brown Scott A.
Eisen Bruce M.
Genetics Institute Inc.
Kapinos Ellen A.
Schain Howard E.
LandOfFree
Homogeneous erythropoietin compositions and methods of using sam does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Homogeneous erythropoietin compositions and methods of using sam, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Homogeneous erythropoietin compositions and methods of using sam will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-2220740